These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24892181)

  • 1. [Not Available].
    Krome S
    Gesundheitswesen; 2014 Apr; 76(4):181. PubMed ID: 24892181
    [No Abstract]   [Full Text] [Related]  

  • 2. The global burden of drug use and mental disorders.
    Lynskey MT; Strang J
    Lancet; 2013 Nov; 382(9904):1540-2. PubMed ID: 23993279
    [No Abstract]   [Full Text] [Related]  

  • 3. Developing accuracy when estimating Global Burden of Disease (GBD) in mental and substance use disorders using complex research methodology, refined data analysis and community participation.
    Yearwood EL
    Evid Based Ment Health; 2014 Nov; 17(4):105. PubMed ID: 24667733
    [No Abstract]   [Full Text] [Related]  

  • 4. Data watch. What is the cost of ADM (alcohol and drug abuse and mental health) in the U.S.?
    Behav Healthc Tomorrow; 1998 Apr; 7(2):18-9, 31. PubMed ID: 10178432
    [No Abstract]   [Full Text] [Related]  

  • 5. Global Burden Of Disease Studies: Implications For Mental And Substance Use Disorders.
    Whiteford H; Ferrari A; Degenhardt L
    Health Aff (Millwood); 2016 Jun; 35(6):1114-20. PubMed ID: 27269030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future Surveillance of Mental Disorders in the United States: Count People, Not Disorders.
    Merikangas KR; Bromet EJ; Druss BG
    JAMA Psychiatry; 2017 May; 74(5):431-432. PubMed ID: 28329225
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence and consequences of dual diagnosis.
    Buckley PF; Brown ES
    J Clin Psychiatry; 2006 Jul; 67(7):e01. PubMed ID: 17107226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of mental and substance use disorders in Indigenous Australians and Oceania.
    Charlson FJ; Erskine HE
    Australas Psychiatry; 2015 Dec; 23(6 Suppl):13-6. PubMed ID: 26634661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary: improving the mental health and substance use estimates in the Global Burden of Disease study: strengthening the evidence base for public policy.
    Whiteford HA; Degenhardt L; Murray CJ; Vos T; Lopez AD
    Int J Epidemiol; 2014 Apr; 43(2):296-301. PubMed ID: 24639446
    [No Abstract]   [Full Text] [Related]  

  • 10. The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010.
    Whiteford HA; Ferrari AJ; Degenhardt L; Feigin V; Vos T
    PLoS One; 2015; 10(2):e0116820. PubMed ID: 25658103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010?
    Whiteford HA; Ferrari AJ; Baxter AJ; Charlson FJ; Degenhardt L
    Curr Opin Psychiatry; 2013 Jul; 26(4):376-83. PubMed ID: 23689547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The course and treatment of substance use disorder in persons with severe mental illness.
    Mueser KT; Drake RE; Miles KM
    NIDA Res Monogr; 1997; 172():86-109. PubMed ID: 9154267
    [No Abstract]   [Full Text] [Related]  

  • 13. Substance use and HIV risk among people with severe mental illness.
    Cournos F; McKinnon K
    NIDA Res Monogr; 1997; 172():110-29. PubMed ID: 9154268
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of comorbidity: major mental illness and problematic substance use.
    Cohen SI
    Aust N Z J Psychiatry; 1999 Aug; 33(4):601. PubMed ID: 10483859
    [No Abstract]   [Full Text] [Related]  

  • 15. Substance use disorders and mental illness: the relevance of comorbidity.
    el-Guebaly N
    Can J Psychiatry; 1995 Feb; 40(1):2-3. PubMed ID: 7874670
    [No Abstract]   [Full Text] [Related]  

  • 16. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs.
    Jané-Llopis E; Matytsina I
    Drug Alcohol Rev; 2006 Nov; 25(6):515-36. PubMed ID: 17132571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
    Mangrum LF; Spence RT; Lopez M
    J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The triply diagnosed: patients with major mental illness, cognitive impairment, and substance abuse.
    Strain EC; Buccino DL; Brooner RK; Schmidt CW; Bigelow GE
    J Nerv Ment Dis; 1993 Sep; 181(9):585-7. PubMed ID: 8245929
    [No Abstract]   [Full Text] [Related]  

  • 19. National and sub-national prevalence, trend, and burden of mental disorders and substance abuse in Iran: 1990 - 2013, study protocol.
    Naserbakht M; Djalalinia S; Tayefi B; Gholami M; Eftekhar Ardabili M; Shariat SV; Taban M; Hajebi A; Behtaj F; Sajadi SA; Rahimi-Movaghar A; Moradi-Lakeh M; Farzadfar F
    Arch Iran Med; 2014 Mar; 17(3):182-8. PubMed ID: 24621361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and burden of mental and substance use disorders in Australia: Findings from the Global Burden of Disease Study 2015.
    Ciobanu LG; Ferrari AJ; Erskine HE; Santomauro DF; Charlson FJ; Leung J; Amare AT; Olagunju AT; Whiteford HA; Baune BT
    Aust N Z J Psychiatry; 2018 May; 52(5):483-490. PubMed ID: 29325437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.